(Q35150857)

6 August 2017

1 reference

title

Glycosaminoglycans in prophylaxis against venous thromboembolism (English)

1 reference

6 August 2017

Glycosaminoglycans in Prophylaxis Against Venous Thromboembolism (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

20 November 2023

main subject

venous thromboembolism

1 reference

D. Bergqvist

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279950

8 September 2022

B. Lindblad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279950

8 September 2022

T. Mätzsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279950

8 September 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

6 August 2017

http://link.springer.com/content/pdf/10.1007/978-1-4899-2444-5_26

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Advances in Experimental Medicine and Biology

20 November 2023

published in

1 reference

6 August 2017

313

1 reference

6 August 2017

259-274

1 reference

A comparative study of Dextran 70 and a sulphated polysaccharide in the prevention of postoperative thromboembolic complications

6 August 2017

8

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

A sulphated polysaccharide - the effects in vivo and in vitro on the haemostatic system in healthy volunteers

20 November 2023

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis

20 November 2023

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis

20 November 2023

12

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia--is there a risk?

20 November 2023

14

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery

20 November 2023

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation

20 November 2023

17

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis

20 November 2023

18

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis

20 November 2023

19

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

20 November 2023

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Thrombosis prophylaxis with low molecular weight heparin in total hip replacement

20 November 2023

23

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group

20 November 2023

25

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardization

20 November 2023

26

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Prophylaxis of Deep Vein Thrombosis in Patients with Fracture of the Femoral Neck:A Prospective Comparison between Dextran and a Sulphated Polysaccharide

20 November 2023

27

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis.

20 November 2023

28

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or Dextran 70

20 November 2023

31

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

20 November 2023

35

37

839

S Haas

1987

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Drug prevention of postoperative deep vein thrombosis. A compararative study of calcium heparinate and sodium pentosan polysulfate

20 November 2023

38

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

A comparative study of low doses of heparin and a heparin analogue in the prevention of postoperative deep vein thrombosis

20 November 2023

40

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis

20 November 2023

41

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery

20 November 2023

45

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine

20 November 2023

46

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.

20 November 2023

49

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement

20 November 2023

50

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

A novel anti-thrombotic heparinoid (ORG 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal models

20 November 2023

56

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

The influence of surgical trauma on factor XaI and IIaI activity and heparin concentration after a single dose of low-molecular-weight heparin.

20 November 2023

61

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

In vivo activity of a new heparinoid

20 November 2023

62

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man

20 November 2023

66

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Clinical studies with low molecular weight heparins in the prevention and treatment of venous thromboembolism

20 November 2023

67

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis

20 November 2023

68

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

20 November 2023

Klinische Wochenschrift

69

62

249

U Schmitz-Hübner

1984

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery

20 November 2023

72

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

A heparin analogue with specific action on antithrombin III

20 November 2023

74

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

20 November 2023

75

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke

20 November 2023

76

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery. A placebo controlled study

20 November 2023

77

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Low dose heparin and compression stockings in the prevention of postoperative deep venous thrombosis

20 November 2023

78

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

A randomized study of a semisynthetic heparin analogue and heparin in prophylaxis of deep vein thrombosis

20 November 2023

79

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Conventional heparin and semisynthetic heparin analogue (SSHA) alteration of blood coagulation after embolic occlusion of human renal circulation

20 November 2023

80

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo

20 November 2023

82

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins

20 November 2023

83

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

20 November 2023

84

38

120

D Welzel

1988

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery: a randomized trial.

20 November 2023

85

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Failure in prophylactic management of thromboembolic disease in colorectal surgery

20 November 2023

86

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

Prevention of postoperative deep-vein thrombosis with perioperative subcutaneous heparin

20 November 2023

87

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

The effect of low molecular weight heparin on experimental thrombosis and haemostasis--the influence of production method

20 November 2023

89

1 reference

https://api.crossref.org/works/10.1007/978-1-4899-2444-5_26

20 November 2023

Identifiers

0 references

1 reference